While taxane resistance is likely multifactorial, the upregulation of the transcription factor HIF-1a, a critical regulator of the hypoxic response, has been shown to protect BC cells from taxane treatment-induced apoptosis [29]. The gene discussed is HIF1A; the disease is breast cancer.